Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells
- PMID: 8648690
- PMCID: PMC190231
- DOI: 10.1128/JVI.70.6.3561-3570.1996
Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells
Abstract
The purpose of this study was to gain insights into the regulation of Epstein-Barr virus (EBV) gene transcription during the establishment of viral latency in B cells. During the early stages of EBV infection in B lymphocytes, transcription of six viral nuclear antigens (EBNAs) is initiated from an early promoter (Wp). This is followed by a switch of promoter usage to an upstream promoter, Cp, whose activity is autoregulated by both EBNA1 and EBNA2. Previously it was demonstrated that infection of primary B cells with EBNA2-negative (EBNA2-) EBNA4-mutant (EBNA4mut) virus resulted only in the expression of mutant EBNA4 protein and failure to express the other EBNA gene products (C. Rooney H. G. Howe, S. H. Speck, and G. Miller, J. Virol. 63:1531-1539, 1989). We extended this research to demonstrate that Wp-to-Cp switching did not occur upon infection of primary B cells with an EBNA2- EBNA4mut virus (M. Woisetschlaeger, X. W. Jin, C. N. Yandara, L. A. Furmanski, J. L. Strominger, and S. H. Speck, Proc. Natl. Acad. Sci. USA 88:3942-3946, 1991). Further characterization of this phenomenon led to the identification of an EBNA2-dependent enhancer upstream of Cp. On the basis of these data, a model was proposed in which initial transcription from Wp gives rise to the expression of EBNA2 and EBNA4, and then transcription is upregulated from Cp via the EBNA2- dependent enhancer (Woisetschlaeger et al., as noted above). Implicit in this model is that transcription of the EBNA1 and EBNA3a to -3c genes is dependent on the switch from Wp to Cp, since primary cells infected with EBNA2- EBNA4mut virus fail to switch and also fail to express these viral antigens. Here we critically evaluate this model and demonstrate, in contrast to the predictions of the model, that transcription of both the EBNA1 and EBNA2 genes precedes activation of Cp. Furthermore, the level of EBNA1 gene transcription was strongly reduced in primary B cells infected with EBNA2- EBNA4mut virus compared with that of cells infected with wild-type virus. Switching to Cp, as well as EBNA1 gene transcription, was observed upon infection of EBV-negative Burkitt's lymphoma (BL) cell lines with EBNA2- EBNA4mut virus, thus establishing a correlation between early EBNA1 gene transcription and upregulation of transcription initiation from Cp. However, in EBV-negative BL cell lines infected with EBNA2- EBNA4mut virus, transcription of the EBNA1 gene at early time points postinfection initiated from Qp, the EBNA1 gene promoter active in group I BL cells (B. C. Schaefer, J. L. Strominger, and S. H. Speck, Proc. Natl. Acad. Sci. USA 92:10565-10569, 1995), rather than from Wp. The data support a model in which EBNA1 plays an important role in the cascade of events leading to successful switching from Wp to Cp and subsequent immortalization of the infected B cell.
Similar articles
-
Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines.J Virol. 2000 Dec;74(23):11115-20. doi: 10.1128/jvi.74.23.11115-11120.2000. J Virol. 2000. PMID: 11070007 Free PMC article.
-
B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1.J Virol. 1997 Dec;71(12):9134-42. doi: 10.1128/JVI.71.12.9134-9142.1997. J Virol. 1997. PMID: 9371570 Free PMC article.
-
Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter.J Virol. 1992 May;66(5):2846-52. doi: 10.1128/JVI.66.5.2846-2852.1992. J Virol. 1992. PMID: 1313905 Free PMC article.
-
EBNA2 and Its Coactivator EBNA-LP.Curr Top Microbiol Immunol. 2015;391:35-59. doi: 10.1007/978-3-319-22834-1_2. Curr Top Microbiol Immunol. 2015. PMID: 26428371 Review.
-
Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation.Adv Cancer Res. 2003;89:133-56. doi: 10.1016/s0065-230x(03)01004-2. Adv Cancer Res. 2003. PMID: 14587872 Review.
Cited by
-
Molecular virology of Epstein-Barr virus.Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):437-59. doi: 10.1098/rstb.2000.0781. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11313004 Free PMC article. Review.
-
EBV miRNA expression profiles in different infection stages: A prospective cohort study.PLoS One. 2019 Feb 13;14(2):e0212027. doi: 10.1371/journal.pone.0212027. eCollection 2019. PLoS One. 2019. PMID: 30759142 Free PMC article.
-
Regulation of EBNA gene transcription in lymphoblastoid cell lines: characterization of sequences downstream of BCR2 (Cp).J Virol. 1997 Jan;71(1):120-8. doi: 10.1128/JVI.71.1.120-128.1997. J Virol. 1997. PMID: 8985330 Free PMC article.
-
Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoid cell lines.J Virol. 2001 Jul;75(13):5796-811. doi: 10.1128/JVI.75.13.5796-5811.2001. J Virol. 2001. PMID: 11390581 Free PMC article.
-
oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.J Virol. 1996 Sep;70(9):5758-68. doi: 10.1128/JVI.70.9.5758-5768.1996. J Virol. 1996. PMID: 8709191 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous